Dr. Chandar Thakur, chief of the Medical Devices and Diagnostics Branch at DHA R&D-MRDC’s Office of Regulated Activities, is the 2024 Employee of the Year.

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.

The US Food and Drug Administration (FDA) has approved Uplizna (inebilizumab-cdon) as the first and only treatment for adults ...

This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) and the ...

The high court’s ruling effectively bans flavored vape products because of concerns that they could appeal to kids.

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

Lifestyle adjustments can help prevent UTIs. While not a proven cure, cranberry products and D-mannose supplements may help ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...

Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...

This decision to put off the differential pricing was taken during a meeting in Gandhinagar of the governing body of the ...